| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |